The global cognitive and memory enhancer drugs market is expected to grow at a CAGR of 5.5 percent during the forecast period. Cognitive and memory enhancer drugs are supplements or medications that promote cognitive functional improvement. These are primarily used to treat patients with schizophrenia, stroke, Alzheimer's disease, attention deficit hyperactivity disorder (ADHD), or geriatric patients. 

 The global surface protein gp 120 market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in March 2021, Gilead Sciences Inc. and Merck have jointly entered into a partnership to co-develop and co-commercialize the long-acting and investigational treatment combinations of Lenacapvir and Islatravir in HIV.

The global ortho biological products market is anticipated to grow at a considerable CAGR of 4.3% during the forecast period (2022-2028). The growing utilization of biologic agents such as platelet-rich plasma and stem cell therapy along with the rise in cell-based matrices is expected to offer lucrative growth opportunities in the global ortho biological products market. Furthermore, increasing adoption of bone marrow aspirate concentrate, adipose-derived stromal cells, and autologous conditioned serum is also expected to boost the market.

The global high-affinity nerve growth factor receptor market is anticipated to grow at a significant CAGR of 5.4% during the forecast period 2022-2028. The major factor attributed to the growth of the market is the rising prevalence of atopic dermatitis across the globe. As per the information provided by the National Eczema Association which highlighted the fact that around 9.6 million US children under the age of 18 have atopic dermatitis, along with one-third have moderate to severe diseases, and childhood atopic dermatitis has steadily increased from 8% to 12% since 1997. 

The global nicotine patch market is anticipated to grow at a significant CAGR of 7.0% during the forecast period 2022-2028. The major factor attributed to the market growth is the increased awareness among people regarding smoking health hazards. Additionally, the major players in the global nicotine patch market are going for collaborations and mergers in order to develop new products and medications.  For instance, in January 2021, Johnson & Johnson donated nicotine patches to help thousands of Jordanians quit smoking during COVID-19. Through its partnership with the Access Initiative for Quitting Tobacco (AIQT, Johnson & Johnson Consumer Health donated its first-ever contribution of nicotine replacement treatment to Jordan's Ministry of Health). 

The global fampridine market is expected to grow at a significant rate during the forecast (2022-2028). The key companies operating in the industry are highly inclined to adopt numerous growth strategies including partnerships collaborations, mergers and acquisitions, geographical expansion, and new product introductions to fulfill the growing market demands that is the key factor driving the market growth For instance, in December 2018, Hikma Pharmaceuticals USA Inc., formerly known as West-Ward Pharmaceuticals Corp., launched Dalfampridine Extended-release Tablets, 10 mg, the generic pharmaceutical equivalent to Ampyra, according to Hikma Pharmaceuticals PLC. Apart from these, the significant approvals to drug developed by market players is further helping in the market growth. Such as,  in May 2021, Bojian Company announced that Fampridine Sustained-Release Tablets had been approved by China's National Medical Products Administration for the treatment of multiple sclerosis (MS) in adult patients with a walking disorder. Fampridine sustained-release pills are the first medication in China to improve the walking capacity of adult MS patients. Fampridine sustained-release pills are among the first batch of clinically urgently needed international new medications. 

The global hyperthermia treatment for cancer market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). Increase in incidence of different types of cancer and rise in diagnosis rate are the key factors boosting the growth of the market. The most common cancers diagnosed in men are prostate, lung, and colorectal cancers which account for an estimated 43% while for women most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in 2020. Governments in developed countries such as the U.S. raise funds for cancer research to aid in the diagnosis and treatment. 

The global hypertension drugs market is anticipated to grow at a considerable CAGR of 4% during the forecast period (2022-2028). The major players operating in the global hypertension drug market adopts various strategies including acquisitions, partnerships, collaborations, and new product launch to stay competitive in the market. For instance, in December 2021, Alembic Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) to market Selexipag tablets, which are used to treat high blood pressure. 

The global disposable surgical kits market is anticipated to grow at a significant CAGR of 7.0% during the forecast period 2022-2028. The major factor driving the growth of the market is the new product launches by the major players operating in the market coupled with rising awareness for cost-effective surgical kits. For instance, MolecuLight Inc. announced the launch of its new Sterile Surgical Sleeve Convenience Kit in July 2020, which can be used to image bacteria in wounds in a surgical and/or isolation scenario. 

The global IT services outsourcing market is anticipated to grow at a considerable CAGR of 6.9 % during the forecast period (2022-2028). Many IT solutions being used for e-commerce such as teleworking and cloud computing, which are provided by IT services outsourcing companies. This is considered to be the primary factor which is boosting the market growth. The rapid expansion of the e-commerce sector across the globe is supporting the IT outsourcing services market. The companies are announcing various launches, acquisitions, and investments in e-commerce which directly supports the IT outsourcing market. For instance, in June 2021, MasterCard invested an undisclosed amount in Instamojo, a payments firm, to help digitize online stores and process their payments more seamlessly.